×
MedSchool: Ace Your OSCEsThe Medical Company
 
 
 
 
 
GET - On the App Store
View
Drug Guide
 
 

Pertuzumab

 
Bookmark
 View Topic Outline
  •  
    IV infusion
    Pertuzumab
    Inhibits ligand-dependent HER2 dimerisation and signalling

  • Mechanism of Action

  • A monoclonal antibody directed against the HER2 receptor, which is involved in cell signalling and is overexpressed in certain cancers. Inhibition of HER2 signalling pathways results in cell cycle arrest; the monoclonal antibody also mediates antibody-dependent cell-mediated cytotoxicity.

Clinical Use

  • Indications

  • HER2 positive breast cancer
  • Adverse Effects
  • Cardiac dysfunction
  • Bone marrow suppression - leucopaenia, anaemia, thrombocytopaenia
  • Immunosuppression (susceptibility to infection)
  • Nausea / vomiting / diarrhoea
  • Abdominal pain
  • Dyspnoea / wheeze
  • Peripheral neuropathy
  • Arthralgias / myalgias
  • Headache
  • Dizziness
  • Flushing
  • Weight loss
  • Insomnia
  • Rash
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now
   
 
 

Snapshot: Initialising...